Genome Variation in Precision Medicine

While GWAS and epigenomics have gone a long way to map the regulatory variation in the human genome that is relevant to medical traits and epidemiological risk of disorders, sequencing based strategies are increasingly employed to dig ever deeper into the full spectrum of common, low frequency and rare variation that contributes to health and disease. At the same time, international consortia are making inroads into the constitutional and somatic variation that drives a range of
cancers. This meeting provides a forum to connect these promising discoveries with the very practical need to develop from genomics a causal understanding of pathogenesis and mechanisms of diseases. At the same time, we expect to find therapeutic targets and biomarkers for improving clinical practice and public health. This is the meeting in which to coordinate this field and to have these discussions.

This conference, co-organized by Nature Genetics, Chinese Academy of Medical Sciences and Anhui Medical University
in China and, will discuss the new progress in the genetic and genomic analysis of diseases and explore the challenges and roadblocks for moving beyond into medical biology. The following topics will be covered in the conference:

Common variants in disease
Analysis of low frequency variants
Translational genomics
Workshop: Somatic variants in cancer

编辑： meeting201